Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2013
12/19/2013WO2013185180A1 Method for identifying a diagnostic biomarker for an antibody of interest
12/19/2013WO2013185165A1 Cd-52 antibodies and their use in determining and enhancing an immune response in a subject
12/19/2013WO2013159204A4 Substances detection system and method
12/19/2013WO2013157917A3 A biosensor and preparation method thereof
12/19/2013WO2013138259A3 Polypeptides for treating and/or limiting influenza infection
12/19/2013WO2013056122A8 Engineered outer domain (eod) of hiv gp120 and mutants thereof
12/19/2013WO2012175183A8 Determination of direct thrombin inhibitors in fluids like serum or urine
12/19/2013US20130339057 Computerized method and system for inferring genetic findings for a patient
12/19/2013US20130338936 Method and system for carbon accounting
12/19/2013US20130338929 Computerized method and system for inferring genetic findings for a patient
12/19/2013US20130338243 Method of predicting acute appendicitis
12/19/2013US20130338194 Predicting Atrial Fibrillation Recurrence by Protease and Protease Inhibitor Profiling
12/19/2013US20130338144 uPAR-uPA INTERACTION INHIBITORS AND METHODS FOR TREATING CANCER
12/19/2013US20130338092 Compounds and methods for targeting leukemic stem cells
12/19/2013US20130338091 HUMAN BetaV-TUBULIN ANTIBODY AND METHODS OF USE
12/19/2013US20130338059 Methods for Differentiating Between Disease States
12/19/2013US20130338047 Screening assays and methods
12/19/2013US20130338044 Bioconjugation using bifunctional linkers
12/19/2013US20130338034 Metabolic diseases-related odorant receptor genes and use thereof
12/19/2013US20130338033 Diagnostic and Prognostic Markers for Metastasis
12/19/2013US20130338031 Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same
12/19/2013US20130338030 Screening assays and methods
12/19/2013US20130338029 Method for a highly sensitive detection and quantification of biomolecules using secondary ion mass spectrometry (sims) and related technologies
12/19/2013US20130338028 Taz/wwtr1 for diagnosis and treatment of cancer
12/19/2013US20130338027 Predictive Markers For Cancer and Metabolic Syndrome
12/19/2013US20130338026 Prognostic Marker for Endometrial Carcinoma
12/19/2013US20130338024 Class ii human histone deacetylases, and uses related thereto
12/19/2013US20130338021 Methods and compositions for the detection of complications of diabetes
12/19/2013US20130338016 Method For Integrated Pathology Diagnosis And Digital Biomarker Pattern Analysis
12/19/2013US20130338014 Calibration Standards For Digital Histocytometry
12/19/2013US20130338013 Substrates and optical systems and methods of use thereof
12/19/2013US20130338009 High-throughput methodology for identifying rna-protein interactions transcriptome-wide
12/19/2013US20130337580 Immunoassay Device and Method
12/19/2013US20130337579 Methods for Determining Protein Ligand Binding
12/19/2013US20130337571 Biological sample measuring device and method for measuring biological sample using same
12/19/2013US20130337570 Method for quantitative analysis of sugars, sugar alcohols and related dehydration products
12/19/2013US20130337567 Nanowire field-effect transistor biosensor with improved sensitivity
12/19/2013US20130337545 Minicell based delivery of biologically active compounds
12/19/2013US20130337544 Methods and composition for the identification of antibiotics that are not susceptible to antibiotic resistance
12/19/2013US20130337536 Labeling Reagents and Methods of Their Use
12/19/2013US20130337501 Cell analyzing apparatus and cell analyzing method
12/19/2013US20130337499 Method of detecting coliform bacteria from reflected light
12/19/2013US20130337488 Method and System for Measuring the Pharmacokinetics of Liposomal Curcumin and its Metabolite Tetrahydrocurcumin
12/19/2013US20130337487 In vitro embryo blastocyst prediction methods
12/19/2013US20130337479 Biomarker for cognitive dysfunction diseases, and method for detection of cognitive dysfunction diseases using the biomarker
12/19/2013US20130337476 URINARY sCD14 AS A BIOMARKER FOR CORONARY ARTERY DISEASE
12/19/2013US20130337474 Detection of acute myeloid leukaemia
12/19/2013US20130337473 Cell identification systems and methods using functionalized micropallet arrays
12/19/2013US20130337472 Cell division marker
12/19/2013US20130337470 METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMadCAM LEVELS
12/19/2013US20130337469 Method for detecting a target molecule in a biological sample
12/19/2013US20130337468 Competitive biosensor having elevated sensitivity
12/19/2013US20130337466 Method for diagnosing alzheimer's disease using biomaterial
12/19/2013US20130337463 Cell-Based Models of Neurodegenerative Disease
12/19/2013US20130337461 Method for diagnosis, monitoring the efficacy of a therapy and for development of treatment for multiple sclerosis
12/19/2013US20130337458 Human trophoblast stem cells and and methods of therapeutic screening
12/19/2013US20130337452 Methods For Rapid Forensic Analysis Of Mitochondrial DNA
12/19/2013US20130337446 Method of preparing a standard diagnostic gene transcript pattern
12/19/2013US20130337445 Method for the clinical development and medical application of multiplex assays derived from patterns of individual biomarkers of oxidative or nitrosative stress
12/19/2013US20130337443 Methods for detecting dna prioginating from different individuals
12/19/2013US20130337441 Combined histological stain
12/19/2013US20130337437 Process for detecting cells from a sample
12/19/2013US20130337433 Process for producing three-dimensional tissue
12/19/2013US20130337432 Diagnostic systems and cartridges
12/19/2013US20130337119 Device and Method for Interactive Programming of a Beverage Brewing Apparatus
12/19/2013US20130337003 Engineered Type IV Pilin of Clostridium difficile
12/19/2013US20130336989 Methods of identifying a patient population
12/19/2013US20130336983 Prognosis and treatment of breast cancer
12/19/2013US20130336979 Diagnostic and treatment of chronic heart failure
12/19/2013US20130336969 Use of olfactomedin-4 protein (olfm4) in colorectal cancer diagnosis
12/19/2013US20130336960 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
12/19/2013US20130336959 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
12/19/2013US20130336910 Olfactory receptors involved in the perception of sweat carboxylic acids and the use thereof
12/19/2013US20130336895 Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
12/19/2013US20130336892 Chimeric t1r taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric t1r polypeptides
12/19/2013US20130336886 Tumor specific antibodies and uses therefor
12/19/2013US20130336885 Anti-lgr5 antibodies and immunoconjugates
12/19/2013US20130336883 Deoxycytidine kinase binding compounds
12/19/2013US20130336841 Catalyst deterioration determination system
12/19/2013US20130334420 Process for Predicting Hematocrit of Whole Blood Using IR Light
12/19/2013US20130334418 Smart tunable diode lase module
12/19/2013US20130334417 Method and device for detecting smoke
12/19/2013US20130334412 Method and Apparatus for Analyzing Composition of Hydrocarbon and Carbon Dioxide Gases Liberated from Drilling Fluids
12/19/2013US20130333721 Nanopore device wetting
12/19/2013US20130333460 Method and system for measuring the composition of a multiphase well sample
12/19/2013US20130333450 Systems and methods for monitoring a solid-liquid interface
12/19/2013DE102013210864A1 Method for determining pore size and pore distribution in metal casting, involves grouping measured pores size and spaces in cluster for generating measuring value for pores size or pores distribution in sample on cluster-to-cluster basis
12/19/2013DE102012210183A1 Anordnung und Verfahren zur Analyse von Nukleinsäuresequenzen Arrangement and method for the analysis of nucleic acid sequences
12/19/2013DE102012210090A1 Teststation für tragbare Gasmessgeräte Test station for portable gas detectors
12/19/2013DE102012210077A1 Verfahren und Anordnung zur Markierung von Zellen in einer Zellsuspension Method and arrangement for labeling of cells in a cell suspension
12/19/2013DE102012012589A1 Core holder for characteristic analysis of test specimens, has feedthrough that is formed on front side arranged cover element, through which fluid is introduced under pressure in cavity from axial direction
12/19/2013CA2877505A1 Antibodies and conjugates that target misfolded prion protein
12/19/2013CA2876802A1 A method and a kit for the in vitro diagnosis of pancreatic ductal adenocarcinoma or for determining the predisposition to pancreatic ductal adenocarcinoma
12/19/2013CA2876731A1 Methods of detecting diseases or conditions
12/19/2013CA2876636A1 Fixed dosage regimens for anti-type i interferon receptor (ifnar) antibodies
12/19/2013CA2876486A1 Methods and compositions for personalized medicine by point-of-care devices for fsh, lh, hcg and bnp
12/19/2013CA2876469A1 Transgenic mouse models for mc4r
12/19/2013CA2876405A1 Methods, reagents and kits for detecting minimal residual disease
12/19/2013CA2876402A1 Protein expression analyses for identifying genotoxic compounds
12/19/2013CA2876330A1 Food safety indicator
1 ... 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 ... 3937